No differences of carotid intima-media thickness between young patients with ankylosing spondylitis and healthy controls

Joint Bone Spine

Volumn 75, Issue 5, 2008, Pages 548-553

  Choe, Jung Yoon ^a   Lee, Myoung Yong ^b   Rheem, Insoo ^b   Rhee, Moo Yong ^c   Park, Sung Hoon ^a   Kim, Seong Kyu ^a  

^a Catholic University of Daegu   (South Korea)

^b Dankook University   (South Korea)

^c Dongguk University College of Medicine   (South Korea)

Author keywords

Ankylosing spondylitis; Intima media thickness

Indexed keywords

INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANKYLOSING SPONDYLITIS; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; ECHOGRAPHY; ELASTICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LABORATORY DIAGNOSIS; MALE; PARAMETER; PROTEIN BLOOD LEVEL;

ADULT; ATHEROSCLEROSIS; CAROTID ARTERIES; CHEMOKINE CCL2; CROSS-SECTIONAL STUDIES; ELASTIC MODULUS; FEMALE; HUMANS; INTERLEUKIN-6; MALE; SPONDYLITIS, ANKYLOSING; TUMOR NECROSIS FACTOR-ALPHA; TUNICA INTIMA; TUNICA MEDIA;

EID: 53349092021     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbspin.2007.11.007     Document Type: Article

References (30)

1. Sieper J., Braun J., Rudwaleit M., et al. Ankylosing spondylitis: an overview. Ann Rheum Dis 3 Suppl. (2002) iii8-iii18
2. Chung C.P., Oeser A., Raggi P., et al. Increased coronary-artery atherosclerosis in rheumatoid arthritis: relationship to disease duration and cardiovascular risk factors. Arthritis Rheum 52 (2005) 3045-3053
3. Ward M.M. Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus. Arthritis Rheum 42 (1999) 338-346
4. Lautermann D., and Braun J. Ankylosing spondylitis - cardiac manifestations. Clin Exp Rheumatol 28 Suppl. (2002) S11-S15
5. Peters M.J., van der Horst-Bruinsma I.E., Dijkmans B.A., et al. Cardiovascular risk profile of patients with spondylarthropathies, particularly ankylosing spondylitis and psoriatic arthritis. Semin Arthritis Rheum 34 (2004) 585-592
6. Lehtinen K. Mortality and causes of death in 398 patients admitted to hospital with ankylosing spondylitis. Ann Rheum Dis 52 (1993) 174-176
7. Sari I., Okan T., Akar S., et al. Impaired endothelial function in patients with ankylosing spondylitis. Rheumatology (Oxford) 45 (2006) 283-286
8. Caliskan M., Erdogan D., Gullu H., et al. Impaired coronary microvascular and left ventricular diastolic functions in patients with ankylosing spondylitis. Atherosclerosis 196 (2008) 306-312
9. Divecha H., Sattar N., Rumley A., et al. Cardiovascular risk parameters in men with ankylosing spondylitis in comparison with non-inflammatory control subjects: relevance of systemic inflammation. Clin Sci (Lond) 109 (2005) 171-176
10. Bal A., Unlu E., Bahar G., et al. Comparison of serum IL-1 β, sIL-2R, IL-6, and TNF-α levels with disease activity parameters in ankylosing spondylitis. Clin Rheumatol 26 (2007) 211-215
11. Takeya M., Yoshimura T., Leonard E.J., et al. Detection of monocyte chemoattractant protein-1 in human atherosclerotic lesions by an anti-monocyte chemoattractant protein-1 monoclonal antibody. Hum Pathol 24 (1993) 534-539
12. Yla-Herttuala S., Lipton B.A., Rosenfeld M.E., et al. Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. Proc Natl Acad Sci U S A 88 (1991) 5252-5256
13. Bots M.L., Hofman A., De Jong P.T., et al. Common carotid intima-media thickness as an indicator of atherosclerosis at other sites of the carotid artery. The Rotterdam Study. Ann Epidemiol 6 (1996) 147-153
14. Oliver J.J., and Webb D.J. Noninvasive assessment of arterial stiffness and risk of atherosclerotic events. Arterioscler Thromb Vasc Biol 23 (2003) 554-566
15. Malesci D., Niglio A., Mennillo G.A., et al. High prevalence of metabolic syndrome in patients with ankylosing spondylitis. Clin Rheumatol 26 (2007) 710-714
16. van der Linden S., Valkenburg H.A., and Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27 (1984) 361-368
17. Braun J., Pham T., Sieper J., et al., ASAS Working Group. International ASAS consensus statement for the use of anti-tumour necrosis factor agents in patients with ankylosing spondylitis. Ann Rheum Dis 62 (2003) 817-824
18. Touboul P.J., Vicaut E., Labreuche J., et al., Paroi Arterielle et Risque Cardiovasculaire Study Investigators. Design, baseline characteristics and carotid intima-media thickness reproducibility in the PARC study. Cerebrovasc Dis 19 (2005) 57-63
19. Alan S., Ulgen M.S., Akdeniz S., et al. Intima-media thickness and arterial distensibility in Behcet's disease. Angiology 55 (2004) 413-419
20. Jourdan C., Wuhl E., Litwin M., et al. Normative values for intima-media thickness and distensibility of large arteries in healthy adolescents. J Hypertens 23 (2005) 1707-1715
21. Henry R.M., Kostense P.J., Spijkerman A.M., et al. Arterial stiffness increases with deteriorating glucose tolerance status: the Hoorn Study. Circulation 107 (2003) 2089-2095
22. Widlansky M.E., Gokce N., Keaney Jr. J.F., et al. The clinical implications of endothelial dysfunction. J Am Coll Cardiol 42 (2003) 1149-1160
23. Anderson T.J., Uehata A., Gerhard M.D., et al. Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol 26 (1995) 1235-1241
24. Ghilardi G. Carotid stenotic-obliterative lesions: distribution in 16,379 subjects 45-75 years of age. Minerva Cardioangiol 42 (1994) 345-350
25. Kullo I.J., Gau G.T., and Tajik A.J. Novel risk factors for atherosclerosis. Mayo Clin Proc 75 (2000) 369-380
26. Francois R.J., Neure L., Sieper J., et al. Immunohistological examination of open sacroiliac biopsies of patients with ankylosing spondylitis: detection of tumour necrosis factor α in two patients with early disease and transforming growth factor β in three more advanced cases. Ann Rheum Dis 65 (2006) 713-720
27. Vazquez-Del M.M., Garcia-Gonzalez A., Munoz-Valle J.F., et al. Interleukin 1beta (IL-1beta), IL-10, tumor necrosis factor-alpha, and cellular proliferation index in peripheral blood mononuclear cells in patients with ankylosing spondylitis. J Rheumatol 29 (2002) 522-526
28. Dawson T.C., Kuziel W.A., Osahar T.A., et al. Absence of CC chemokine receptor-2 reduces atherosclerosis in apolipoprotein E-deficient mice. Atherosclerosis 143 (1999) 205-211
29. Dragomir E., Tircol M., Manduteanu I., et al. Aspirin and PPAR-alpha activators inhibit monocyte chemoattractant protein-1 expression induced by high glucose concentration in human endothelial cells. Vascul Pharmacol 44 (2006) 440-449
30. Kim M.P., Wahl L.M., Yanek L.R., et al. A monocyte chemoattractant protein-1 gene polymorphism is associated with occult ischemia in a high-risk asymptomatic population. Atherosclerosis 193 (2007) 366-372